Kamuran A. Kadipasaoglu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kamuran A. Kadipasaoglu has a total of 212 co-authors. Here are the top co-authors by number of shared publications:
Egemen Tuzun
10 shared publicationsJeff L. Conger
7 shared publicationsKazuhiro Eya
Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, Texas 77225-0345, USA
7 shared publicationsO H Frazier
7 shared publicationsO. H. Frazier
7 shared publicationsBranislav Radovancevic
5 shared publications
Latest Publications
- 1 October 2014
- Published by Elsevier in Medical Image Analysis
- Vol. 18 (7) , 1217-1232
Comparing algorithms for automated vessel segmentation in computed tomography scans of the lung: the VESSEL12 study
- 1 October 2014
- Published by Elsevier in Medical Image Analysis
- Vol. 18 (7) , 1217-1232
Comparing algorithms for automated vessel segmentation in computed tomography scans of the lung: the VESSEL12 study
- 1 May 2013
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 59 (3) , 230-239
Design and Numeric Evaluation of a Novel Axial-Flow Left Ventricular Assist Device
Virtual design characteristics and performance of the first Turkish axial-flow left ventricular assist device (LVAD) are presented, with emphasis on rotor geometry. The patented rotor design includes a central flow channel carved inside the main block, which carries permanent magnets. A concentric rotor-stator gap minimizes the distance between respective magnets, improving electromagnetic efficiency and creating a second blood pathway. Dual sets of three helical blades, placed on the shaft and external surface of the rotor block, ensure unidirectionality. Hemodynamic performance was tested with computational fluid dynamics (CFD); and rotor-blade geometry was optimized, to maximize overall efficiency d and minimize backflow and wall shear stresses. For a shaft radius of 4.5 mm, rotor blade height of 2.5 mm, and blade inlet and exit metal angles of 67° and 32°, pump operation at the nominal head-flow combination (5L/min and 100.4 mm Hg) was achieved at a rotor speed of 10,313rpm. At the nominal point, backflow as percent of total flow was 7.29 and 29.87% at rotor inlet and exit, respectively; overall hydraulic efficiency reached 21.59%; and maximum area-averaged shroud shear was 520 Pa. Overall efficiency peaked at 24.07% for a pump flow of 6.90L/min, and averaged at 22.57% within the flow range of 4–8L/min. We concluded that the design satisfies initial rotor design criteria, and that continued studies with diffuser optimization and transient flow analysis are warranted.
- 1 May 2013
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 59 (3) , 230-239
Design and Numeric Evaluation of a Novel Axial-Flow Left Ventricular Assist Device
Virtual design characteristics and performance of the first Turkish axial-flow left ventricular assist device (LVAD) are presented, with emphasis on rotor geometry. The patented rotor design includes a central flow channel carved inside the main block, which carries permanent magnets. A concentric rotor-stator gap minimizes the distance between respective magnets, improving electromagnetic efficiency and creating a second blood pathway. Dual sets of three helical blades, placed on the shaft and external surface of the rotor block, ensure unidirectionality. Hemodynamic performance was tested with computational fluid dynamics (CFD); and rotor-blade geometry was optimized, to maximize overall efficiency d and minimize backflow and wall shear stresses. For a shaft radius of 4.5 mm, rotor blade height of 2.5 mm, and blade inlet and exit metal angles of 67° and 32°, pump operation at the nominal head-flow combination (5L/min and 100.4 mm Hg) was achieved at a rotor speed of 10,313rpm. At the nominal point, backflow as percent of total flow was 7.29 and 29.87% at rotor inlet and exit, respectively; overall hydraulic efficiency reached 21.59%; and maximum area-averaged shroud shear was 520 Pa. Overall efficiency peaked at 24.07% for a pump flow of 6.90L/min, and averaged at 22.57% within the flow range of 4–8L/min. We concluded that the design satisfies initial rotor design criteria, and that continued studies with diffuser optimization and transient flow analysis are warranted.
- 1 April 2013
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-4
Region growing on frangi vesselness values in 3-D CTA data
In cardiac related diagnostic methods, the shape and curvature of coronary arteries is essential. Consequently, one of the most important requirements for Computer Aided Diagnosis (CAD) Systems is automated segmentation of vasculature. In this paper, we propose a new hybrid algorithm, which segment the coronary arterial tree in CTA images by merging methodologies-, namely, Region Growing and Frangi Approach. The algorithm first runs a region growing on Frangi vesselness values and subsequently optimizes the results with several threshold values. Comparison of the present results with optimal results of existing segmentation algorithms reveals that the proposed approach outperforms its predecessors. The diagnostic accuracy of the algorithm will next be validated on the segmentation of coronary arteries from real CT data.
- 1 April 2013
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-4
Region growing on frangi vesselness values in 3-D CTA data
In cardiac related diagnostic methods, the shape and curvature of coronary arteries is essential. Consequently, one of the most important requirements for Computer Aided Diagnosis (CAD) Systems is automated segmentation of vasculature. In this paper, we propose a new hybrid algorithm, which segment the coronary arterial tree in CTA images by merging methodologies-, namely, Region Growing and Frangi Approach. The algorithm first runs a region growing on Frangi vesselness values and subsequently optimizes the results with several threshold values. Comparison of the present results with optimal results of existing segmentation algorithms reveals that the proposed approach outperforms its predecessors. The diagnostic accuracy of the algorithm will next be validated on the segmentation of coronary arteries from real CT data.
- 1 April 2013
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-4
Automated aortic supravalvular sinus detection in conventional computed tomography image
Valvular diseases are those where one or more of the cardiac valves are affected. Treatment of valvular diseases often involves replacement or restoration of the affected valve(s). In such a surgical procedure, the medical expert performing the procedure can largely benefit from a patient-specific and dynamic valvular model containing information complementary to the 2D/3D static images. To this end, in this study a novel automated supravalvular sinus detection method (to be used as a first step in aortic valve segmentation) on conventional contrast-enhanced ECG-gated multislice CT data and its evaluation on expert annotated 31 real cases are presented. Results demonstrate a highly accurate detection performance with average error rate inferior to 1.12 mm.
- 1 April 2013
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-4
Automated aortic supravalvular sinus detection in conventional computed tomography image
Valvular diseases are those where one or more of the cardiac valves are affected. Treatment of valvular diseases often involves replacement or restoration of the affected valve(s). In such a surgical procedure, the medical expert performing the procedure can largely benefit from a patient-specific and dynamic valvular model containing information complementary to the 2D/3D static images. To this end, in this study a novel automated supravalvular sinus detection method (to be used as a first step in aortic valve segmentation) on conventional contrast-enhanced ECG-gated multislice CT data and its evaluation on expert annotated 31 real cases are presented. Results demonstrate a highly accurate detection performance with average error rate inferior to 1.12 mm.
- 1 May 2008
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 54 (3) , 249-255
Continuous Flow Total Artificial Heart: Modeling and Feedback Control in a Mock Circulatory System
We developed a mock circulatory loop and used mathematical modeling to test the in vitro performance of a physiologic flow control system for a total artificial heart (TAH). The TAH was constructed from two continuous flow pumps. The objective of the control system was to maintain loop flow constant in response to changes in outflow resistance of either pump. Baseline outflow resistances of the right (pulmonary vascular resistance) and the left (systemic vascular resistance) pumps were set at 2 and 18 Wood units, respectively. The corresponding circuit flow was 4 L/min. The control system consisted of two digital integral controllers, each regulating the voltage, hence, the rotational speed of one of the pumps. The in vitro performance of the flow control system was validated by increasing systemic and pulmonary vascular resistances in the mock loop by 4 and 8 Wood units (simulating systemic and pulmonary hypertension conditions), respectively. For these simulated hypertensive states, the flow controllers regulated circuit flow back to 4 L/min within seconds by automatically adjusting the rotational speed of either or both pumps. We conclude that this multivariable feedback mechanism may constitute an adequate supplement to the inherent pressure sensitivity of rotary blood pumps for the automatic flow control and left-right flow balance of a dual continuous flow pump TAH system.
- 1 May 2008
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 54 (3) , 249-255
Continuous Flow Total Artificial Heart: Modeling and Feedback Control in a Mock Circulatory System
We developed a mock circulatory loop and used mathematical modeling to test the in vitro performance of a physiologic flow control system for a total artificial heart (TAH). The TAH was constructed from two continuous flow pumps. The objective of the control system was to maintain loop flow constant in response to changes in outflow resistance of either pump. Baseline outflow resistances of the right (pulmonary vascular resistance) and the left (systemic vascular resistance) pumps were set at 2 and 18 Wood units, respectively. The corresponding circuit flow was 4 L/min. The control system consisted of two digital integral controllers, each regulating the voltage, hence, the rotational speed of one of the pumps. The in vitro performance of the flow control system was validated by increasing systemic and pulmonary vascular resistances in the mock loop by 4 and 8 Wood units (simulating systemic and pulmonary hypertension conditions), respectively. For these simulated hypertensive states, the flow controllers regulated circuit flow back to 4 L/min within seconds by automatically adjusting the rotational speed of either or both pumps. We conclude that this multivariable feedback mechanism may constitute an adequate supplement to the inherent pressure sensitivity of rotary blood pumps for the automatic flow control and left-right flow balance of a dual continuous flow pump TAH system.
- 1 March 2006
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 52 (2) , 145-149
Total Heart Replacement Using Dual Intracorporeal Continuous-Flow Pumps in a Chronic Bovine Model: A Feasibility Study
Continuous-flow pumps are small, simple, and respond physiologically to input variations, making them potentially ideal for total heart replacement. However, the physiological effects of complete pulseless flow during long-term circulatory support without a cardiac interface or with complete cardiac exclusion have not been well studied. We evaluated the feasibility of dual continuous-flow pumps as a total artificial heart (TAH) in a chronic bovine model. Both ventricles of a 6-month-old Corriente crossbred calf were excised and sewing rings attached to the reinforced atrioventricular junctions. The inlet portions of 2 Jarvik 2000 pumps were positioned through their respective sewing rings at the mid-atrial level and the pulseless atrial reservoir connected end-to-end to the pulmonary artery and aorta. Pulseless systemic and pulmonary circulations were thereby achieved. Volume status was controlled, and systemic and pulmonary resistance were managed pharmacologically to keep mean arterial pressures at 100+/-10 mmHg (systemic) and 20+/-5 mmHg (pulmonary) and both left and right atrial pressures at 15+/-5 mmHg. The left pump speed was maintained at 14,000 rpm and its output autoregulated in response to variations in right pump flow, systemic and pulmonary pressures, fluid status, and activity level. Hemodynamics, end-organ function, and neurohormonal status remained normal. These results suggest the feasibility of using dual continuous-flow pumps as a TAH.
- 1 March 2006
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 52 (2) , 145-149
Total Heart Replacement Using Dual Intracorporeal Continuous-Flow Pumps in a Chronic Bovine Model: A Feasibility Study
Continuous-flow pumps are small, simple, and respond physiologically to input variations, making them potentially ideal for total heart replacement. However, the physiological effects of complete pulseless flow during long-term circulatory support without a cardiac interface or with complete cardiac exclusion have not been well studied. We evaluated the feasibility of dual continuous-flow pumps as a total artificial heart (TAH) in a chronic bovine model. Both ventricles of a 6-month-old Corriente crossbred calf were excised and sewing rings attached to the reinforced atrioventricular junctions. The inlet portions of 2 Jarvik 2000 pumps were positioned through their respective sewing rings at the mid-atrial level and the pulseless atrial reservoir connected end-to-end to the pulmonary artery and aorta. Pulseless systemic and pulmonary circulations were thereby achieved. Volume status was controlled, and systemic and pulmonary resistance were managed pharmacologically to keep mean arterial pressures at 100+/-10 mmHg (systemic) and 20+/-5 mmHg (pulmonary) and both left and right atrial pressures at 15+/-5 mmHg. The left pump speed was maintained at 14,000 rpm and its output autoregulated in response to variations in right pump flow, systemic and pulmonary pressures, fluid status, and activity level. Hemodynamics, end-organ function, and neurohormonal status remained normal. These results suggest the feasibility of using dual continuous-flow pumps as a TAH.
- 24 August 2005
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 101
Transmyocardial Laser Revascularization (TMLR) At the Texas Heart Institute
- 24 August 2005
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 101
Transmyocardial Laser Revascularization (TMLR) At the Texas Heart Institute
- 1 May 2005
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 51 (3) , 224-229
Total Heart Replacement with Dual Centrifugal Ventricular Assist Devices
In an ovine feasibility study, we implanted two HeartMate-III centrifugal ventricular assist devices (VADs) for total heart replacement. With cardiopulmonary bypass support, both ventricles were transected at the atrioventricular groove, preserving a rim of ventricular tissue. The atrioventricular valves were excised, and the aorta and pulmonary artery were transected above the ventriculoarterial valves. An interatrial septal window was created by excising the foramen ovale. The VADs’ sewing rings were attached to the left and right ventricular remnants, respectively. Outflow grafts were anastomosed to the aorta and pulmonary artery. The left VAD operated continuously at 4,500 rpm. Right VAD speed increased from 2,000 to 4,500 rpm in 500 rpm increments. Outflow graft flow, pressure, oxygen saturation, and shunt direction were recorded. The pulmonary artery to aortic ratio of flow and pressure increased from 0.26 and 0.15 (at 2,000 rpm) to 1.21 and 0.53, respectively (at 4,500 rpm). The interatrial shunt, which was right to left at lower right VAD speeds, progressed to bidirectional, then to left dominant as right VAD speed increased. Outflow-graft oxygen saturation was reflective of the shunt direction. In this acute experiment, total heart replacement with continuous flow VADs satisfactorily balanced left and right ventricular flows and preserved the physiologic circulatory response.
- 1 May 2005
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 51 (3) , 224-229
Total Heart Replacement with Dual Centrifugal Ventricular Assist Devices
In an ovine feasibility study, we implanted two HeartMate-III centrifugal ventricular assist devices (VADs) for total heart replacement. With cardiopulmonary bypass support, both ventricles were transected at the atrioventricular groove, preserving a rim of ventricular tissue. The atrioventricular valves were excised, and the aorta and pulmonary artery were transected above the ventriculoarterial valves. An interatrial septal window was created by excising the foramen ovale. The VADs’ sewing rings were attached to the left and right ventricular remnants, respectively. Outflow grafts were anastomosed to the aorta and pulmonary artery. The left VAD operated continuously at 4,500 rpm. Right VAD speed increased from 2,000 to 4,500 rpm in 500 rpm increments. Outflow graft flow, pressure, oxygen saturation, and shunt direction were recorded. The pulmonary artery to aortic ratio of flow and pressure increased from 0.26 and 0.15 (at 2,000 rpm) to 1.21 and 0.53, respectively (at 4,500 rpm). The interatrial shunt, which was right to left at lower right VAD speeds, progressed to bidirectional, then to left dominant as right VAD speed increased. Outflow-graft oxygen saturation was reflective of the shunt direction. In this acute experiment, total heart replacement with continuous flow VADs satisfactorily balanced left and right ventricular flows and preserved the physiologic circulatory response.
- 1 March 2005
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 51 (2) , 139-143
The Effect of Intermittent Low Speed Mode Upon Aortic Valve Opening in Calves Supported With a Jarvik 2000 Axial Flow Device
We assessed the effects of an axial flow left ventricular assist device (LVAD) upon aortic valve opening, pump outflow, and biologic and hematologic parameters when operated in intermittent low speed (ILS) mode. An ILS controller equipped Jarvik 2000 LVAD was implanted in six calves. Pump speed was maintained at 10,000 rpm, and pump outflow was measured throughout the study period (71 ± 6 days [mean ± SD]). Hematologic and biochemical parameters were analyzed daily for the first 10 days, weekly for the first month, and biweekly thereafter to monitor for kidney or liver dysfunction, hemolysis, bleeding, or infection. Before study termination, esmolol hydrochloride was infused to induce low cardiac output and totally impair aortic valve opening. Radiopaque cineaortography was performed over 30 second intervals (10 seconds before, 10 seconds during, and 10 seconds immediately after ILS controller activation) to assess the effect of ILS mode upon aortic valve opening. After study termination, major end organs and the major vascular tree were removed and examined macroscopically and histologically for thrombus formation and infarction; the aortic valve was examined for thickening and fusion. All pumps were explanted and examined for thrombus formation. All six calves recovered without surgical or mechanical complications. Hematologic and biochemical parameters did not change significantly between baseline and study termination. The aortic valve successfully opened when ILS mode was activated, even under low cardiac output conditions. No thrombus was detected in the major end organs and vascular tree, except for some small renal infarcts in three calves that did not affect renal function. These results indicate that operating an axial flow LVAD in ILS mode allows aortic valve opening and aortic root washout.
- 1 March 2005
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 51 (2) , 139-143
The Effect of Intermittent Low Speed Mode Upon Aortic Valve Opening in Calves Supported With a Jarvik 2000 Axial Flow Device
We assessed the effects of an axial flow left ventricular assist device (LVAD) upon aortic valve opening, pump outflow, and biologic and hematologic parameters when operated in intermittent low speed (ILS) mode. An ILS controller equipped Jarvik 2000 LVAD was implanted in six calves. Pump speed was maintained at 10,000 rpm, and pump outflow was measured throughout the study period (71 ± 6 days [mean ± SD]). Hematologic and biochemical parameters were analyzed daily for the first 10 days, weekly for the first month, and biweekly thereafter to monitor for kidney or liver dysfunction, hemolysis, bleeding, or infection. Before study termination, esmolol hydrochloride was infused to induce low cardiac output and totally impair aortic valve opening. Radiopaque cineaortography was performed over 30 second intervals (10 seconds before, 10 seconds during, and 10 seconds immediately after ILS controller activation) to assess the effect of ILS mode upon aortic valve opening. After study termination, major end organs and the major vascular tree were removed and examined macroscopically and histologically for thrombus formation and infarction; the aortic valve was examined for thickening and fusion. All pumps were explanted and examined for thrombus formation. All six calves recovered without surgical or mechanical complications. Hematologic and biochemical parameters did not change significantly between baseline and study termination. The aortic valve successfully opened when ILS mode was activated, even under low cardiac output conditions. No thrombus was detected in the major end organs and vascular tree, except for some small renal infarcts in three calves that did not affect renal function. These results indicate that operating an axial flow LVAD in ILS mode allows aortic valve opening and aortic root washout.
- 1 February 2005
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 24 (2) , 226-228
Evaluation of myocardial function in patients with end-stage heart failure during support with the Jarvik 2000 left ventricular assist device
- 1 February 2005
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 24 (2) , 226-228
Evaluation of myocardial function in patients with end-stage heart failure during support with the Jarvik 2000 left ventricular assist device